ArticleCancer cell international2023

Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells.

Kou Nishikubo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.